Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2023-06-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
[기재정정]증권발행결과(자율공시)(제3자배정 유상증자-전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Inventage Lab regarding the 'Results of Securities Issuance' (증권 발행결과) specifically for a third-party paid-in capital increase (private placement of convertible preferred shares). It details the issuance of new shares, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-06-19 Korean
증권발행결과(자율공시)(제1회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding a private placement of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments that can be converted into equity.
2023-06-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Inventage Lab, specifically detailing the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market regarding capital structure changes and financing activities. Since it details the terms, purpose, and issuance of debt instruments, it falls under the 'Capital/Financing Update' category.
2023-06-09 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Inventage Lab, specifically detailing a 'Third-Party Allocation Capital Increase' (유상증자결정). It outlines the number of new shares, issuance price, purpose of funds, and detailed terms regarding convertible preferred shares, call options, and board resolutions. This is a formal regulatory filing regarding a capital change/share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-06-09 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Inventage Lab' (주식회사 인벤티지랩) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business descriptions, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders and special related parties, including specific transaction dates and reasons for changes (e.g., exclusion of special related parties). This type of filing is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2023-04-28 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.